Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5) - Image 1

£149.86

Springer Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)

Name: Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)
Brand: Springer
Price: 149.24 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 87 days • 87 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 87 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £149 (53 days, 60.9%)

Price range: £149 - £150

Price levels: 2 different prices over 87 days

Description

This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar- keted or are under clinical testing. In previous volumes of this series,funda- mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise. The way from theory to practice isnot alwaysobvious and straightforward. There isa need for practical examples of how the principles and theories are put into use, specificallyin the development of a pharmaceutical product. It is our hope that this volume will fulfillsuch a need. Itisnot asimple task to choose a panel ofproteinsand peptides from the over 200 agents in human clinical trials. We have tried to collect a wide representation of molecules of different sizes-from 10 amino acids (Leu- prolide) to 1020 amino acids (Muromonab CD3). The examples include agents derived from various sources including monoclonal antibodies (Mur- omonab CD3), recombinant DNA (human and bovine growth hormones), natural source (fibrolase), and chemical synthesis (Leuprolide). Clearly this list is not intended to be encyclopedic. It isthe first time a collection of this sort has been made accessibleto the formulation scientists involved in devel- oping protein and peptide products. Although each chapter in this volume focuses primarily on the charac- terization and stability of a specific molecule, each has unique aspects.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 148991238X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 31 May 2013
Listed Since: 18 April 2014

Barcode

No barcode data available

Springer Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Stability and Characterization of Protein Drugs Vol 5

CRC Press - Pharmaceutical Formulation of Peptides and Proteins

Formulation, Characterization, and Stability of Protein Drugs: Case Histories: 9 (Pharmaceutical Biotechnology, 9)

CRC Press Therapeutic Peptides and Proteins, 3rd Edition

Methods for Structural Analysis of Protein Pharmaceuticals: III (Biotechnology: Pharmaceutical Aspects, III)

Springer - Protein Pharmacokinetics and Metabolism: 1

Protein Homeostasis in Drug Discovery: A Chemical Biology Perspective

Springer - Physical Biology of Proteins and Peptides Book

Introduction to Peptides and Proteins

Peptide and Protein Drug Analysis

Springer Biobetters: Protein Engineering to Approach the Curative

Therapeutic Proteins and Peptides (Volume 112) (Advances in Protein Chemistry and Structural Biology, Volume 112)

Peptide and Protein Drug Analysis: 101 (Drugs and the Pharmaceutical Sciences)

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

Springer Handbook of Stability Testing in Pharmaceutical Development

CRC Press Proteins and Peptides - Drug Development Guide

Lyophilized Biologics and Vaccines: Modality-Based Approaches

Humana Therapeutic Proteins: Methods and Protocols: 308

Surfactants in Biopharmaceutical Development

Protein-based Therapeutics

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

From Molecules to Medicines: Structure of Biological Macromolecules and Its Relevance in Combating New Diseases and Bioterrorism (NATO Science for Peace and Security Series A: Chemistry and Biology)

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)